Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
amgen
5
×
boston blog main
boston top stories
5
×
clinical trials
5
×
deals
5
×
life sciences
national blog main
national top stories
biotech
fda
new york blog main
new york top stories
san francisco blog main
san francisco top stories
boulder/denver blog main
boulder/denver top stories
cancer
detroit blog main
detroit top stories
eli lilly
indiana blog main
indiana top stories
national
raleigh-durham blog main
raleigh-durham top stories
rna interference
san diego blog main
san diego top stories
sanofi
seattle blog main
seattle top stories
startups
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
alnylam pharmaceuticals
bristol-myers squibb
cancer drugs
glaxosmithkline
What
bio
roundup
cancer
cash
drug
medicines
acquire
agreed
alliance
alzheimer’s
appetite
billion
black
bread
brings
bristol
butter
buy
buyout
calls
changing
cholesterol
color
company
compound
congress
crispr
days
deal
democrats
despite
diabetes
diamond’s
divided
drugs
elections
eli
fallout
family
fda
Language
unset
Current search:
deals
×
" boston top stories "
×
" clinical trials "
×
amgen
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
4 years ago
Revolution Medicines IPO Reels In $238M to Take On RAS in Cancer
@xconomy.com
4 years ago
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B
@xconomy.com
5 years ago
Bio Roundup: #JPM19 Notes, Loxo Buyout, Black Diamond’s Cash & More
@xconomy.com
5 years ago
Bio Roundup: Midterm Fallout, Alzheimer’s Search, Postpartum Panel
